Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
about
Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on StoolEffects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection.Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin.Second-line rescue therapy of helicobacter pylori infection.Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.Helicobacter pylori resistance to rifabutin in the last 7 years.Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Review article: the global emergence of Helicobacter pylori antibiotic resistance.Helicobacter pylori eradication therapy.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Attempts to enhance the eradication rate of Helicobacter pylori infectionMechanisms of Helicobacter pylori antibiotic resistance and molecular testing.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction.Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.Microarray-Based Detection and Clinical Evaluation for Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 PatientsResistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance
P2860
Q33710414-AA3B8950-D421-40B7-A54A-AEE07F2C7FB6Q33751142-0F3A6927-A112-42A0-91B8-A4044285F36EQ33983562-8A239B8E-A08F-4D55-A00B-B76E92AE9B76Q34409114-8EA0AA89-EDB1-4C35-9904-A7ADAD1C7018Q35005169-E27ED20F-2602-4D07-9ADC-F37E52AEA514Q35066862-475FF894-2A22-45D3-8D54-CD734D57EF76Q35363984-D6D70D09-CC79-4062-9447-1F25EC3EC5C4Q35771863-57EEFF7F-C649-4AB7-8FEF-C6C5D1DDBF28Q36205448-CFC98C88-7E0B-49CC-BD1F-AA8631087B10Q36209645-F888AC03-8A2D-4BB2-A6C8-EE001E19B67FQ37340339-03EA8780-9432-4920-8E7C-70475D0031AAQ37721423-9757CF44-5AA5-4098-AE94-45EBED351DE3Q38029324-EB7566EC-7327-45A1-BFAD-E0B4D2F190A5Q38212213-00B1037E-A553-446B-9FB7-F4E951421C8CQ38490776-2047AB8D-6CAC-428B-8975-F10A6F71E416Q39588933-898E8937-DE8D-45B8-A269-3F3100F3EA70Q40892650-27D8AEFF-7BBA-4A5F-994C-BAFB7F4A1BA9Q41928182-CC5082DE-9F2E-49EF-8AC6-B33FCAAA76E1Q43193083-6D2B6CA9-C15B-41A0-8D04-D2429B12483FQ43218781-EDC75B3C-EBDF-4B71-AC94-47FB385A5D8CQ48600558-59F74593-85CF-4DBE-88B2-5AC0DC2F0E45Q57114157-0B181DED-F84D-433D-9469-E66AF495C114Q57225645-D282F76B-B924-4F9B-82E6-5534C00377B5
P2860
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@en
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@nl
type
label
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@en
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@nl
prefLabel
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@en
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@nl
P2093
P2860
P356
P1476
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
@en
P2093
Hidekazu Suzuki
Toshifumi Hibi
Toshihiro Nishizawa
P2860
P304
P356
10.3164/JCBN.08-220R
P577
2009-02-28T00:00:00Z